Disrupting Glioblastoma’s Deadly Resistance: Dual Therapy Breakthrough
Glioblastoma, a notoriously fatal form of brain cancer, claims the lives of over 95% of patients within five years of diagnosis. The disease’s aggressive nature …
Unleashing Industry Insights, Connecting the Future
Glioblastoma, a notoriously fatal form of brain cancer, claims the lives of over 95% of patients within five years of diagnosis. The disease’s aggressive nature …
What is Genomic Cancer Testing? Genomic cancer testing, also known as tumor profiling or molecular profiling, refers to specialized medical tests that analyze the DNA, …
The global Immuno-Oncology Market is estimated to be valued at US$ 4556.83 Mn or Bn in 2023 and is expected to exhibit a CAGR of …